Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1988 Feb;130(2):401–410.

Differences in lectin binding of malignant pleural mesothelioma and adenocarcinoma of the lung.

T Kawai 1, S D Greenberg 1, L D Truong 1, C A Mattioli 1, M Klima 1, J L Titus 1
PMCID: PMC1880523  PMID: 2449084

Abstract

In order to differentiate between malignant pleural mesothelioma and adenocarcinoma of the lung, the glycoconjugate profiles of 6 reactive mesothelial lesions, 23 mesotheliomas (17 epithelial, 1 desmoplastic, 2 biphasic, and 3 fibrous types), and 28 well-differentiated pulmonary adenocarcinomas were evaluated with the use of 8 lectins in addition to anti-carcinoembryonic, anti-keratin and anti-epithelial membrane antigen. Formalin-fixed, paraffin-embedded tissues were stained with the avidin-biotin peroxidase complex method. Reactions of wheat germ (WGA) and peanut (PNA) agglutinin with neuraminidase treatment lectins were positive in 5 of 6 (83%) and 3 of 6 (50%) cases, respectively, in reactive mesothelial lesions. Thirteen of 23 (57%) malignant mesotheliomas of the pleura showed a positive reaction for WGA and PNA with neuraminidase treatment; other lectins were low-positive, below 9%. In contrast, pulmonary adenocarcinomas showed positive reactions in 27 of 28 cases (96%) for PNA, 26 of 28 (93%) for Ricinus communis (RCA-I), 25 of 28 (89%) for WGA, and 22 of 28 (79%) for succinylated WGA (SucWGA). The findings suggest that malignant pleural mesothelioma and pulmonary adenocarcinoma have consistent and distinct glycoconjugate profiles, and that stains for RCA-I and SucWGA may be useful for differential diagnosis.

Full text

PDF
401

Images in this article

402Figure 1
on p.402
403Figure 2
on p.403
406Figure 3
on p.406
406Figure 4
on p.406
407Figure 5
on p.407
407Figure 6
on p.407

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Battifora H., Kopinski M. I. Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach. Cancer. 1985 Apr 15;55(8):1679–1685. doi: 10.1002/1097-0142(19850415)55:8<1679::aid-cncr2820550812>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  2. Blobel G. A., Moll R., Franke W. W., Kayser K. W., Gould V. E. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. Am J Pathol. 1985 Nov;121(2):235–247. [PMC free article] [PubMed] [Google Scholar]
  3. Burns T. R., Greenberg S. D., Mace M. L., Johnson E. H. Ultrastructural diagnosis of epithelial malignant mesothelioma. Cancer. 1985 Oct 15;56(8):2036–2040. doi: 10.1002/1097-0142(19851015)56:8<2036::aid-cncr2820560825>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  4. Cibas E. S., Corson J. M., Pinkus G. S. The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: the role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen, and milk fat globule-derived antigen. Hum Pathol. 1987 Jan;18(1):67–74. doi: 10.1016/s0046-8177(87)80196-x. [DOI] [PubMed] [Google Scholar]
  5. Colcher D., Hand P. H., Nuti M., Schlom J. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci U S A. 1981 May;78(5):3199–3203. doi: 10.1073/pnas.78.5.3199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cooper H. S. Peanut lectin-binding sites in large bowel carcinoma. Lab Invest. 1982 Oct;47(4):383–390. [PubMed] [Google Scholar]
  7. Corson J. M., Pinkus G. S. Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas. Am J Pathol. 1982 Jul;108(1):80–88. [PMC free article] [PubMed] [Google Scholar]
  8. Gatter K. C., Alcock C., Heryet A., Pulford K. A., Heyderman E., Taylor-Papadimitriou J., Stein H., Mason D. Y. The differential diagnosis of routinely processed anaplastic tumors using monoclonal antibodies. Am J Clin Pathol. 1984 Jul;82(1):33–43. doi: 10.1093/ajcp/82.1.33. [DOI] [PubMed] [Google Scholar]
  9. Ghosh A. K., Gatter K. C., Dunnill M. S., Mason D. Y. Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies. J Clin Pathol. 1987 Jan;40(1):19–25. doi: 10.1136/jcp.40.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Holden J., Churg A. Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma. Am J Surg Pathol. 1984 Apr;8(4):277–279. doi: 10.1097/00000478-198404000-00004. [DOI] [PubMed] [Google Scholar]
  11. Hsu S. M., Raine L., Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol. 1981 May;75(5):734–738. doi: 10.1093/ajcp/75.5.734. [DOI] [PubMed] [Google Scholar]
  12. Kannerstein M., Churg J., Magner D. Histochemistry in the diagnosis of malignant mesothelioma. Ann Clin Lab Sci. 1973 May-Jun;3(3):207–211. [PubMed] [Google Scholar]
  13. Kawai T., Suzuki M., Shinmei M., Maenaka Y., Kageyama K. Glycosaminoglycans in malignant diffuse mesothelioma. Cancer. 1985 Aug 1;56(3):567–574. doi: 10.1002/1097-0142(19850801)56:3<567::aid-cncr2820560325>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  14. Klima M., Bossart M. I. Sarcomatous type of malignant mesothelioma. Ultrastruct Pathol. 1983 Jun;4(4):349–358. doi: 10.3109/01913128309140587. [DOI] [PubMed] [Google Scholar]
  15. Kwee W. S., Veldhuizen R. W., Golding R. P., Mullink H., Stam J., Donner R., Boon M. E. Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining. Virchows Arch A Pathol Anat Histol. 1982;397(3):287–299. doi: 10.1007/BF00496570. [DOI] [PubMed] [Google Scholar]
  16. Lee I., Radosevich J. A., Chejfec G., Ma Y. X., Warren W. H., Rosen S. T., Gould V. E. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12. Am J Pathol. 1986 Jun;123(3):497–507. [PMC free article] [PubMed] [Google Scholar]
  17. Loosli H., Hurlimann J. Immunohistological study of malignant diffuse mesotheliomas of the pleura. Histopathology. 1984 Sep;8(5):793–803. doi: 10.1111/j.1365-2559.1984.tb02395.x. [DOI] [PubMed] [Google Scholar]
  18. Marshall R. J., Herbert A., Braye S. G., Jones D. B. Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium. J Clin Pathol. 1984 Nov;37(11):1215–1221. doi: 10.1136/jcp.37.11.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mazzuca M., Lhermitte M., Lafitte J. J., Roussel P. Use of lectins for detection of glycoconjugates in the glandular cells of the human bronchial mucosa. J Histochem Cytochem. 1982 Sep;30(9):956–966. doi: 10.1177/30.9.7130674. [DOI] [PubMed] [Google Scholar]
  20. Meban C. Lectin binding sites on the surfaces of the pneumonocytes in human neonatal lung. Histochem J. 1986 Apr;18(4):196–202. doi: 10.1007/BF01676121. [DOI] [PubMed] [Google Scholar]
  21. Monsigny M., Roche A. C., Sene C., Maget-Dana R., Delmotte F. Sugar-lectin interactions: how does wheat-germ agglutinin bind sialoglycoconjugates? Eur J Biochem. 1980 Feb;104(1):147–153. doi: 10.1111/j.1432-1033.1980.tb04410.x. [DOI] [PubMed] [Google Scholar]
  22. Nicolson G. L. The interactions of lectins with animal cell surfaces. Int Rev Cytol. 1974;39:89–190. doi: 10.1016/s0074-7696(08)60939-0. [DOI] [PubMed] [Google Scholar]
  23. Otis C. N., Carter D., Cole S., Battifora H. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. A bi-institutional study of 47 cases. Am J Surg Pathol. 1987 Jun;11(6):445–456. doi: 10.1097/00000478-198706000-00005. [DOI] [PubMed] [Google Scholar]
  24. Reano A., Faure M., Jacques Y., Reichert U., Schaefer H., Thivolet J. Lectins as markers of human epidermal cell differentiation. Differentiation. 1982;22(3):205–210. doi: 10.1111/j.1432-0436.1982.tb01252.x. [DOI] [PubMed] [Google Scholar]
  25. Said J. W., Nash G., Tepper G., Banks-Schlegel S. Keratin proteins and carcinoembryonic antigen in lung carcinoma: an immunoperoxidase study of fifty-four cases, with ultrastructural correlations. Hum Pathol. 1983 Jan;14(1):70–76. doi: 10.1016/s0046-8177(83)80048-3. [DOI] [PubMed] [Google Scholar]
  26. Sheibani K., Battifora H., Burke J. S. Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen. Am J Pathol. 1986 May;123(2):212–219. [PMC free article] [PubMed] [Google Scholar]
  27. Sheibani K., Battifora H., Burke J. S., Rappaport H. Leu-M1 antigen in human neoplasms. An immunohistologic study of 400 cases. Am J Surg Pathol. 1986 Apr;10(4):227–236. doi: 10.1097/00000478-198604000-00001. [DOI] [PubMed] [Google Scholar]
  28. Sloane J. P., Ormerod M. G. Distribution of epithelial membrane antigen in normal and neoplastic tissues and it value in diagnostic tumor pathology. Cancer. 1981 Apr 1;47(7):1786–1795. doi: 10.1002/1097-0142(19810401)47:7<1786::aid-cncr2820470711>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  29. Szpak C. A., Johnston W. W., Roggli V., Kolbeck J., Lottich S. C., Vollmer R., Thor A., Schlom J. The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3). Am J Pathol. 1986 Feb;122(2):252–260. [PMC free article] [PubMed] [Google Scholar]
  30. Teshima S., Hirohashi S., Shimosato Y., Kishi K., Ino Y., Matsumoto K., Yamada T. Histochemically demonstrable changes in cell surface carbohydrates of human germ cell tumors. Lab Invest. 1984 Mar;50(3):271–277. [PubMed] [Google Scholar]
  31. Walts A. E., Said J. W., Shintaku I. P., Sassoon A. F., Banks-Schlegel S. Keratins of different molecular weight in exfoliated mesothelial and adenocarcinoma cells--an aid to cell identification. Am J Clin Pathol. 1984 Apr;81(4):442–446. doi: 10.1093/ajcp/81.4.442. [DOI] [PubMed] [Google Scholar]
  32. Wang N. S. Electron microscopy in the diagnosis of pleural mesotheliomas. Cancer. 1973 May;31(5):1046–1054. doi: 10.1002/1097-0142(197305)31:5<1046::aid-cncr2820310502>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  33. Wang N. S., Huang S. N., Gold P. Absence of carcinoembryonic antigen-like material in mesothelioma: an immunohistochemical differentiation from other lung cancers. Cancer. 1979 Sep;44(3):937–943. doi: 10.1002/1097-0142(197909)44:3<937::aid-cncr2820440322>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  34. Yonezawa S., Nakamura T., Tanaka S., Sato E. Glycoconjugate with Ulex europaeus agglutinin-I-binding sites in normal mucosa, adenoma, and carcinoma of the human large bowel. J Natl Cancer Inst. 1982 Oct;69(4):777–785. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES